Elevation Oncology has raised nearly $200M since its launch just two years ago. $200 million! That sounds like an enormous amount of investment capital, but when the company is potentially changing cancer treatment as we know it - you can see why investors are excited about Elevation's potential. Today, founder and CEO Shawn Leland tells us all about the raises, challenges and excitement of growing his company.

ncG1vNJzZmivp6x7q7DSrqermV6YvK57y56emqSemsS0e9OhnGaqkaeybq3Iq2Sonl2auabCwK2gqKZdpLuku8uonrJlopa2tHmPcG5uaV8%3D